Received Jun 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
had 3 shots; Suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a elderly female patient who received Herpes zoster (Shingles vaccine) solution for injection for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingles vaccine. In SEP-2025, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). On an unknown date, the patient experienced extra dose administered (Verbatim: had 3 shots). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved and the outcome of the extra dose administered was not applicable. The reporter considered the vaccination failure and shingles to be unrelated to Shingles vaccine. The company considered the vaccination failure and shingles to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 27-MAY-2026 This case was reported by patient via interactive digital media. The patient was 88 years old at the time of reporting and got shingles last SEP-2025, they stayed around 7 months, she had 3 shots for them quite some time before she got them. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The batch number was not provided upon follow-up with the reporter.; Sender's Comments: A case of Vaccination failure, unknown time after receiving 3rd dose, 2nd dose and1st dose of Shingles vaccine, in an elderly female patient. Case lacks further information on time to onset, medical history, concurrent conditions and laboratory confirmation. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.